Definity Rt Injection, Suspension
Product Images NDC 11994-017

5 FDA label images from Lantheus Medical Imaging, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Definity Rt (NDC 11994-017). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lantheus Medical Imaging, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Definity 01)

Chemical Structure (Definity 01)
Chemical structure of perflutren, the active ingredient in DEFINITY RT injection suspension. The diagram shows the molecular arrangement of fluorine atoms in the perflutren compound.*
FDA Label Image

Chemical Structure (Definity 02)

Chemical Structure (Definity 02)
Chemical structure diagram of perflutren, the active ingredient in DEFINITY RT injection suspension. The diagram shows its molecular structure including a sodium salt and phosphonate group.*
FDA Label Image

Chemical Structure (Definity 03)

Chemical Structure (Definity 03)
Chemical structure of perflutren, the active ingredient in DEFINITY RT injection, showing the molecular arrangement with phosphate, ester, and long hydrocarbon components.*
FDA Label Image

Chemical Structure (Definity 04)

Chemical Structure (Definity 04)
Chemical structure of perflutren, the active ingredient in DEFINITY RT injection, suspension. The diagram shows the molecular arrangement and bonding of perflutren, highlighting its fluorocarbon chains and functional groups.*
FDA Label Image

Principal Display Panel (2 mL Vial Carton)

Principal Display Panel (2 mL Vial Carton)
DEFINITY RT injectable suspension (perflutren lipid microsphere) 6.52 mg/mL in 20 x 2 mL vials for intravenous use. The label states it is sterile, non-pyrogenic, and for single patient use. It is distributed by Lantheus Medical Imaging, Inc. Storage instructions note room temperature between 20°C to 25°C (68°F to 77°F). The packaging highlights that this product is not equivalent to other drug products containing perflutren.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.